103 related articles for article (PubMed ID: 25179248)
21. [Dosimetric study of postoperative 3-dimensional conformal radiotherapy and coplanar decile intensity-modulated radiotherapy for cervical cancer].
Jiang J; Zhang L; Liao S; Huagn R
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Aug; 32(8):1201-5. PubMed ID: 22931623
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations.
Huguet F; Goodman KA; Azria D; Racadot S; Abrams RA
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1355-64. PubMed ID: 22768988
[TBL] [Abstract][Full Text] [Related]
23. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies.
Georg P; Georg D; Hillbrand M; Kirisits C; Pötter R
Radiother Oncol; 2006 Jul; 80(1):19-26. PubMed ID: 16766068
[TBL] [Abstract][Full Text] [Related]
24. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer.
van de Water TA; Lomax AJ; Bijl HP; de Jong ME; Schilstra C; Hug EB; Langendijk JA
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1216-24. PubMed ID: 20732761
[TBL] [Abstract][Full Text] [Related]
25. [Preoperative intensity-modulated radiotherapy of rectal cancers: Relevance and modalities].
Randrian V; Biau J; Benoît C; Pezet D; Lapeyre M; Moreau J
Cancer Radiother; 2020 Jul; 24(4):345-353. PubMed ID: 32360094
[TBL] [Abstract][Full Text] [Related]
26. Small bowel toxicity in pelvic radiotherapy for postoperative gynecological cancer: comparison between conformal radiotherapy and intensity modulated radiotherapy.
Ray A; Sarkar B
Asia Pac J Clin Oncol; 2013 Sep; 9(3):280-4. PubMed ID: 23279854
[TBL] [Abstract][Full Text] [Related]
27. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
Ahamad A; D'Souza W; Salehpour M; Iyer R; Tucker SL; Jhingran A; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1117-24. PubMed ID: 15990017
[TBL] [Abstract][Full Text] [Related]
28. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
[TBL] [Abstract][Full Text] [Related]
29. [Intensity-modulated radiotherapy in head and neck cancer: ethics and methodology].
Lapeyre M; Biau J; Miroir J; Servagi-Vernat S; Giraud P
Cancer Radiother; 2014 Oct; 18(5-6):365-8. PubMed ID: 25179256
[TBL] [Abstract][Full Text] [Related]
30. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
31. Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies.
Wong E; D'Souza DP; Chen JZ; Lock M; Rodrigues G; Coad T; Trenka K; Mulligan M; Bauman GS
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):830-41. PubMed ID: 15708263
[TBL] [Abstract][Full Text] [Related]
32. A comparison of out-of-field dose and its constituent components for intensity-modulated radiation therapy versus conformal radiation therapy: implications for carcinogenesis.
Ruben JD; Lancaster CM; Jones P; Smith RL
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1458-64. PubMed ID: 20950947
[TBL] [Abstract][Full Text] [Related]
33. Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin.
Simpson DR; Song WY; Moiseenko V; Rose BS; Yashar CM; Mundt AJ; Mell LK
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e81-6. PubMed ID: 22516388
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
Milby AB; Both S; Ingram M; Lin LL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
[TBL] [Abstract][Full Text] [Related]
35. Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.
Guckenberger M; Meyer J; Baier K; Vordermark D; Flentje M
Radiat Oncol; 2006 Sep; 1():34. PubMed ID: 16956403
[TBL] [Abstract][Full Text] [Related]
36. A dosimetric analysis of intensity-modulated radiation therapy with bone marrow sparing for cervical cancer.
Murakami N; Okamoto H; Kasamatsu T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Toita T; Ito Y; Itami J
Anticancer Res; 2014 Sep; 34(9):5091-8. PubMed ID: 25202097
[TBL] [Abstract][Full Text] [Related]
37. Statistical analysis of dose-volume profiles and its implication for radiation therapy planning in prostate carcinoma.
Vanasek J; Odrazka K; Dolezel M; Kolarova I; Jarkovsky J; Pavlik T; Hlavka A; Dusek L
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):769-76. PubMed ID: 23628133
[TBL] [Abstract][Full Text] [Related]
38. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk.
Ahmed RS; Kim RY; Duan J; Meleth S; De Los Santos JF; Fiveash JB
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):505-12. PubMed ID: 15380585
[TBL] [Abstract][Full Text] [Related]
39. The potential for dose dumping in normal tissues with IMRT for pelvic and H&N cancers.
Reddy NM; Mazur AK; Sampath S; Osian A; Sood BM; Ravi A; Nori D
Med Dosim; 2008; 33(1):55-61. PubMed ID: 18262124
[TBL] [Abstract][Full Text] [Related]
40. Experience-based quality control of clinical intensity-modulated radiotherapy planning.
Moore KL; Brame RS; Low DA; Mutic S
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):545-51. PubMed ID: 21277097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
